Last analyzed: May 28, 2026 (Q4 FY25)

Summit Therapeutics Inc.

SMMT

Biotechnology

$17.41

Market Cap

$14M

P/E Ratio

-14.657693

Revenue Rank

Rank 2

Margin Rank

Rank 2

Performance Parameter: Indicating Future Growth(Based on Quarterly Earnings Call)

Explore More Tools

Discover more ways to research and analyze Indian stocks

Stock RankingsAI-ranked stocks from earnings callsStock ScreenerFilter by P/E, ROE, growth & moreIPO DashboardUpcoming, open & listed IPOsCompare StocksSide-by-side stock comparisonCalculatorsSIP, CAGR, EMI & moreEarnings CalendarUpcoming earnings callsAnalyze PortfolioAI health check for your portfolioBlogMarket insights & guides